Most readers would already know that Abbott Laboratories' (NYSE:ABT) stock increased by 7.2% over the past three months. We wonder if and what role the company's financials play in that price change ...

A St. Louis jury handed Abbott Laboratories a win Thursday, deciding that Abbott, another company and a hospital were not ...

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Abbott Laboratories (NYSE:ABT), together with its subsidiaries, discovers, develops ...

To Dioselina Salto, the first two weeks of motherhood were amazing, even though she spent much of it in the hospital after ...

Shares of Abbott Laboratories are rising and those of Reckitt Benckiser are gaining in London trading Friday, a day after a ...

On Thursday, Abbott Laboratories (ABT) stock saw a decline, ending the day at $115.3 which represents a decrease of $-1.50 or -1.28% from the prior close of $116.8. The stock opened at $117.49 and ...

CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by ...

Following the robust Q3 performance, Piper Sandler raised ABT’s price target to $133 from $131, keeping an Overweight rating ...

Abbott Laboratories showcases robust financial performance with a notable increase in net earnings. Strategic acquisitions ...

In the last three months, 15 analysts have published ratings on Abbott Laboratories (NYSE:ABT), offering a diverse range of perspectives from bullish to bearish. The table below summarizes their ...

On Tuesday, Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $117.73 which represents a slight increase of $0.08 or 0.07% from the prior close of $117.65. The stock opened at ...

Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...